ARTICLE | Company News
Alza, Ribozyme deal
July 22, 1996 7:00 AM UTC
The companies will investigate the use of AZA's drug delivery technology to deliver ribozymes to treat central nervous system disorders. The companies will conduct cell culture and animal studies using local delivery of synthetic ribozymes via AZA's Alzet osmotic pumps. Alzet uses implantable, capsule-shaped units to deliver solutions at controlled rates. ...